Valeant Patient Savings Program
Save up to $60! Up to $20 off each of 3 prescription fills for LACRISERT®.
| Step 1: | Enter your contact information below to receive a rebate for up to $20 off each of 3 prescriptions fills for LACRISERT®. Select the box on the form below if you would also like to learn more about LACRISERT®. Valeant Pharma will only use this information to send your rebate, unless you click the box on the form below indicating that you would like to receive free LACRISERT® information. |
| Step 2: | Once the information is submitted, press the button to view and print your rebate request form. Only 1 rebate is valid per prescription. The rebate will be in the amount of your co-pay, up to $20. |
Indications and Usage
LACRISERT® is indicated in patients with moderate to severe Dry Eye syndromes, including keratoconjunctivitis sicca. LACRISERT® is indicated especially in patients who remain symptomatic after an adequate trial of therapy with artificial tear solutions. LACRISERT® is also indicated for patients with exposure keratitis, decreased corneal sensitivity, and recurrent corneal erosions.
Important Safety Information
LACRISERT® is contraindicated in patients who are hypersensitive to hydroxypropyl cellulose. Instructions for inserting and removing LACRISERT® should be carefully followed. If improperly placed, LACRISERT® may result in corneal abrasion. Because LACRISERT® may cause transient blurred vision, patients should be instructed to exercise caution when driving or operating machinery. Patients should be cautioned against rubbing the eye(s) containing LACRISERT®.
The following adverse reactions have been reported, but were in most instances, mild and temporary: transient blurring of vision, ocular discomfort or irritation, matting or stickiness of eyelashes, photophobia, hypersensitivity, eyelid edema, and hyperemia.
Talk to your doctor if you have side effects that bother you or that do not go away. You are encouraged to report side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.
